FDA Orange Book · active-ingredient family
Indium in-111 pentetate disodium
Indium in-111 pentetate disodium is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:MPI INDIUM DTPA IN 111 · NDA 017707
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MPI INDIUM DTPA IN 111RLD | GE HEALTHCARE | NDA 017707 | — | Feb 18, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Indium in-111 pentetate disodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

